Inventor · disambiguated record
Daniel Oehlrich
Also filed as: OEHLRICH DANIEL
16 granted patents·19 pending applications·81 citations·filing 2010–2022
91Inventor score
Files withJANSSEN PHARMACEUTICA NV22CID-NÚÑEZ JOSÉ MARIA3JANSSEN PHARMACEUTICALS INC3GIJSEN HENRICUS JACOBUS MARIA2CELLZOME LTD1
Top patents by PatentIndex Score
35 records- 0195US8937060B21,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disordersCID-NUNEZ JOSE MARIA·Filed 2010·Granted Jan 20, 2015·39 cites·35 claims
- 0289US9012448B21,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptorsCID-NÚÑEZ JOSÉ MARIA·Filed 2011·Granted Apr 21, 2015·17 cites·13 claims
- 0383US10071095B21,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of neurological and psychiatric disordersJANSSEN PHARMACEUTICALS INC·Filed 2017·Granted Sep 11, 2018·4 cites·19 claims
- 0482US9737533B21,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disordersJANSSEN PHARMACEUTICALS INC·Filed 2015·Granted Aug 22, 2017·3 cites·19 claims
- 0580US9226930B21,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disordersJANSSEN PHARMACEUTICALS INC·Filed 2014·Granted Jan 5, 2016·3 cites·19 claims
- 0677US9271967B21,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptorsCID-NÚÑEZ JOSÉ MARIA·Filed 2011·Granted Mar 1, 2016·4 cites·17 claims
- 0777US8993591B21,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptorsCID-NÚÑEZ JOSÉ MARIA·Filed 2011·Granted Mar 31, 2015·4 cites·9 claims
- 0874US9751886B24-amino-6-phenyl-6,7-dihydro[1,2,3]triazolo[1,5-A]pyrazine derivatives as inhibitors of beta-secretase (BACE)JANSSEN PHARMACEUTICA NV·Filed 2014·Granted Sep 5, 2017·2 cites·13 claims
- 0970US8772504B2Substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulatorsGIJSEN HENRICUS JACOBUS MARIA·Filed 2010·Granted Jul 8, 2014·2 cites·12 claims
- 1069US9834559B24-Amino-6-phenyl-5,6-dihydroimidazo[1,5-a]pyrazin-3(2H)-one derivatives as inhibitors of beta-secretase (BACE)JANSSEN PHARMACEUTICA NV·Filed 2014·Granted Dec 5, 2017·1 cites·10 claims
- 1167US8946266B2Substituted triazole and imidazole derivatives as gamma secretase modulatorsWU TONGFEI·Filed 2010·Granted Feb 3, 2015·2 cites·14 claims
- 1260US2024279223A15-oxo-pyrido[2,3-d]pyridazin-6(5h)-yl acetamidesJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1359US2024239757A1Phthalazinone derivates as nlrp3 inflammasome inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1458US2024109905A14-alkoxy-6-oxo-pyridazine derivatives modulating nlrp3JANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1558US2024174670A14-amino-6-oxo-pyridazine derivatives modulating nlrp3JANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1657US2023391756A1New compoundJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 1756US2023183248A1Pyrrolo[1,2-d][1,2,4]triazine-2-yl-acetamides as inhibitors of the nlrp3 inflammasome pathwayJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 1856US2024043450A1New compoundJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 1956US2023203044A1Pyrazolo[1,5-d][1,2,4]triazine-5(4h)-acetamides as inhibitors of the nlrp3 inflammasomeJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 2055US2023183249A1New triazinoindole compoundsJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 2155US2023202989A1CompoundsJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 2254US2023203064A1Tricyclic compounds as inhibitors of nlrp3JANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 2352US2015094311A1Novel substituted bicyclic heterocyclic compounds as gamma secretase modulatorsCELLZOME LTD·Filed 2014·Application pending·0 cites
- 2450US2023058733A1Oga inhibitor compoundsJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 2550US2023099293A1Oga inhibitor compoundsJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 2645US9580433B24-amino-6-phenyl-5,6-dihydroimidazo[1,5-A]pyrazine derivatives as inhibitors of beta-secretase (BACE)JANSSEN PHARMACEUTICA NV·Filed 2014·Granted Feb 28, 2017·0 cites·15 claims
- 2743US8946426B2Substituted bicyclic heterocyclic compounds as gamma secretase modulatorsGIJSEN HENRICUS JACOBUS MARIA·Filed 2010·Granted Feb 3, 2015·0 cites·9 claims
- 2842US2021284659A1Inhibitors of beta secretaseJANSSEN PHARMACEUTICA NV·Filed 2018·Application pending·0 cites
- 2942US2021130352A1Oga inhibitor compoundsJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 3042US2021277003A1Oga inhibitor compoundsJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 3141US11053248B2[1,2,4]triazolo[1,5-a]pyrimidine compounds as PDE2 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jul 6, 2021·0 cites·9 claims
- 3241US9145399B2Substituted bicyclic triazole derivatives as gamma secretase modulatorsDE CLEYN MICHEL ANNA JOZEF·Filed 2011·Granted Sep 29, 2015·0 cites·4 claims
- 3341US2019389882A1Inhibitors of beta secretaseJANSSEN PHARMACEUTICA NV·Filed 2018·Application pending·0 cites
- 3441US2020010482A1Inhibitors of beta secretaseJANSSEN PHARMACEUTICA NV·Filed 2018·Application pending·0 cites
- 3535US9840507B25,6-dihydro-imidazo[1,2-a]pyrazin-8-ylamine derivatives useful as inhibitors of beta-secretase (BACE)TRABANCO-SUÁREZ ANDRÉS AVELINO·Filed 2011·Granted Dec 12, 2017·0 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →